Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551152-24-000040
Filing Date
2024-11-04
Accepted
2024-11-04 14:19:33
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abbv-20240930.htm   iXBRL 10-Q 2405570
2 EX-31.1 abbv-20240930xex311.htm EX-31.1 9020
3 EX-31.2 abbv-20240930xex312.htm EX-31.2 9266
4 EX-32.1 abbv-20240930xex321.htm EX-32.1 4706
5 EX-32.2 abbv-20240930xex322.htm EX-32.2 4755
11 abbv-20240930_g1.jpg GRAPHIC 15145
12 abbv-20240930_g2.gif GRAPHIC 748
  Complete submission text file 0001551152-24-000040.txt   12122671

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20240930.xsd EX-101.SCH 62163
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20240930_cal.xml EX-101.CAL 103591
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20240930_def.xml EX-101.DEF 412676
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20240930_lab.xml EX-101.LAB 802466
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20240930_pre.xml EX-101.PRE 578578
83 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20240930_htm.xml XML 2425361
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 241422649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)